Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe change consists only of a version revision tag, updating from v3.4.0 to v3.4.1, with no changes to study content or page functionality. To avoid being alert by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor backend update with no visible changes to study content or navigation.SummaryDifference0.0%

- Check56 days agoChange DetectedResults status in the study record changed from 'No Results Posted' to 'Results Submitted'. This indicates that the trial results have been submitted and will be posted.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.